نتائج البحث

Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

• Authors : Mortensen, H.R.; Populaire, P.; Hoffmann, L.

Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology

• Source: ISSN:0167-8140 ; ISSN:1879-0887 ; Radiotherapy And Oncology, vol. 190, Art.No. ARTN 109980.

تفاصيل العنوان

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

• Authors : Hites, Maya; Massonnaud, Clément; Lapique, Eva Larranaga ...

Subjects: MESH: Humans; MESH: Antibodies; Monoclonal

• Source: ISSN: 0163-4453.

تفاصيل العنوان

Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023

• Authors : Dennett, S.; Mello, E.; Holton, J. ...

Subjects: Assaigs clínics; Medicaments antineoplàstics; Càncer

• Source: Scientia

تفاصيل العنوان

Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study.

• Authors : Garcia-Pavia, Pablo; Sultan, Marla B; Gundapaneni, Balarama ...

Subjects: Amyloid Neuropathies; Familial; Cardiomyopathies

تفاصيل العنوان

Releasing the grip of big pharma.

• Authors : Conti Nibali S; Siracusano MF

Subjects: Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/economics ; Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/legislation & jurisprudence ; Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/standards

• Source: Lancet (London, England) [Lancet] 2001 Aug 25; Vol. 358 (9282), pp. 664.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان

How to evaluate the ecologic impact of antibiotics in phase III trials.

• Authors : Carbon C; Service de Médecine Interne, EMI-U 9933, Hôpital Bichat, Paris, France.

Subjects: Clinical Trials, Phase III as Topic* ; Ecosystem*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use

• Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2001; Vol. 7 Suppl 5, pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

Generalisation from phase III clinical trials: survival, quality of life, and health economics.

• Authors : Fayers PM; Unit for Epidemiology and Clinical Research, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Hand DJ

Subjects: Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/Clinical Trials, Phase III as Topic*/economics ; Economics, Medical* ; Quality of Life*

• Source: Lancet (London, England) [Lancet] 1997 Oct 04; Vol. 350 (9083), pp. 1025-7.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer

• Authors : Andreas Rimner; Wei-Chu Victoria Lai; Raffaele Califano

Subjects: Adolescent; Adult; Antibodies

تفاصيل العنوان

AIDS vaccines not ready for phase III trials.

• Authors : Rowe PM

Subjects: AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/adverse effects ; AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; Clinical Trials, Phase III as Topic*

• Source: Lancet (London, England) [Lancet] 1994 Jun 25; Vol. 343 (8913), pp. 1626.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial

• Authors : Park, Keunchil; Ozguroglu, Mustafa; Vansteenkiste, Johan

Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology

• Source: ISSN:0169-5002 ; ISSN:1872-8332 ; Lung Cancer, vol. 154, (92-98.

تفاصيل العنوان